Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.

@article{Ndumele2011HepaticSO,
  title={Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.},
  author={Chiadi E. Ndumele and Khurram Nasir and Raquel Dilguerian de Oliveira Conceiç{\~a}o and Jos{\'e} Ant{\^o}nio Maluf de Carvalho and Roger S. Blumenthal and Raul D Santos},
  journal={Arteriosclerosis, thrombosis, and vascular biology},
  year={2011},
  volume={31 8},
  pages={1927-32}
}
OBJECTIVE The goal of this study was to assess the independent and collective associations of hepatic steatosis, obesity, and the metabolic syndrome with elevated high-sensitivity C-reactive protein (hs-CRP) levels. METHODS AND RESULTS We evaluated 2388 individuals without clinical cardiovascular disease between December 2004 and December 2006. Hepatic steatosis was diagnosed by ultrasound, and the metabolic syndrome was defined using National Heart, Lung, and Blood Institute criteria. The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

A concise review of non-alcoholic fatty liver disease.

Atherosclerosis • 2015
View 5 Excerpts
Highly Influenced

Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.

The Journal of pharmacology and experimental therapeutics • 2014
View 9 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Fatty liver: a novel component of the metabolic syndrome.

Arteriosclerosis, thrombosis, and vascular biology • 2008

Similar Papers

Loading similar papers…